PostEra

PostEra is an AI-driven biotech company building a modern drug discovery engine focused on medicinal chemistry. Its core technology, the Proton platform, is an end-to-end machine learning system designed to close the iterative Design-Make-Test cycle, aiming to reduce the time, cost, and failure rate of developing new medicines. The company pursues a hybrid business model, advancing its own therapeutic pipeline while securing significant validation and funding through high-value collaborations with top pharmaceutical companies like Pfizer and Amgen. Founded in Cambridge, Massachusetts, PostEra has rapidly established itself as a key player in the AI-for-drug-discovery landscape.

Proton, an end-to-end machine learning platform for medicinal chemistry that closes the Design-Make-Test cycle. It integrates foundation models for molecular design, synthesis planning for reliable and parallel synthesis, and active learning for optimal experimental testing.

PostEra competes in the crowded AI-driven drug discovery space with companies like Exscientia, Recursion, Insilico Medicine, and Atomwise. Its key differentiator is a chemistry-first, full-cycle platform focused on synthesizability and parallel synthesis, coupled with early validation from top-tier pharmaceutical partners.